BETTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 787
EU - Europa 527
AS - Asia 180
Totale 1.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 787
PL - Polonia 165
IE - Irlanda 123
IT - Italia 111
VN - Vietnam 76
SE - Svezia 73
CN - Cina 44
HK - Hong Kong 37
ES - Italia 18
JO - Giordania 11
FI - Finlandia 10
DE - Germania 8
GB - Regno Unito 7
BE - Belgio 4
IN - India 3
JP - Giappone 3
TR - Turchia 3
EE - Estonia 2
NL - Olanda 2
RU - Federazione Russa 2
SG - Singapore 2
UA - Ucraina 2
KR - Corea 1
Totale 1.494
Salva come PNG Salva come JPEG
Città #
Warsaw 164
Chandler 123
Dublin 123
Fairfield 100
Ashburn 87
Dong Ket 76
Houston 50
Woodbridge 49
Seattle 47
Wilmington 45
Cambridge 42
Florence 36
Ann Arbor 31
Princeton 25
Beijing 22
Hong Kong 22
Barcelona 17
Altamura 16
Shanghai 14
Lawrence 13
Boston 12
Medford 11
New York 10
Cagliari 7
Kent 6
Boardman 5
Gavirate 5
Ponte 5
Brussels 4
West Jordan 4
Falls Church 3
San Diego 3
Buffalo 2
Hefei 2
Norwalk 2
Parma 2
Pune 2
Tallinn 2
Trumbull 2
Augusta 1
Barnaul 1
Böblingen 1
Cantagallo 1
Castelfranco di Sotto 1
Chongqing 1
Chuxiong 1
Cortona 1
Ferrara 1
Glasgow 1
Hebei 1
Hillsboro 1
Istanbul 1
Jacksonville 1
Kunming 1
Lappeenranta 1
London 1
Madrid 1
Massa 1
Misano Adriatico 1
Moscow 1
Padova 1
Palo Alto 1
Polska 1
Pontassieve 1
Prato 1
Rignano Sull'arno 1
Rotterdam 1
Salerno 1
Sant'elpidio A Mare 1
Seoul 1
Sesto Fiorentino 1
Shaoxing 1
Singapore 1
Stockholm 1
Terracina 1
Washington 1
Totale 1.228
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and pharmacological evaluation of new adenosine receptor ligands 230
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 161
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 117
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 104
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 97
null 90
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 81
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies 76
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 69
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 67
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 58
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 54
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 52
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 50
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 46
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 44
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 43
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 42
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 39
Aminopyridine-3,5-dicarbonitriles as non-nucleoside adenosine A1 receptor agonists. 27
Totale 1.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020248 20 13 8 19 28 24 27 31 23 24 25 6
2020/2021253 9 27 1 30 11 6 4 13 23 36 15 78
2021/2022137 4 10 17 5 3 8 3 6 7 9 23 42
2022/2023416 34 71 33 31 32 73 47 40 42 0 9 4
2023/2024196 3 17 18 5 5 69 4 43 10 7 9 6
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.547